Caris Life Sciences Inc.
CAI | NASDAQ
$32.10
-$2.23 (-6.50%)
At close: Nov 2, 2026, 4:00 PM ET
$32.73
+$0.63 (+1.96%)
After-hours:
Nov 2, 2026, 4:33 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 104.63M | 33.98M | -68.09M | -186.99M | -279.05M | -273.44M | -281.89M | -244.94M | -177.21M | -111.03M | 139.08M | 103.37M | 64.8M |
Depreciation & Amortization | 25.83M | 20.64M | 22.62M | 29.3M | 36.78M | 41.99M | 52.65M | 41.67M | 29.32M | 17.71M | 114.85M | 112.59M | 111.7M |
Stock-Based Compensation | 65.11M | 55.32M | 70.01M | 61.62M | 52.68M | 28.88M | 18.64M | 13.67M | 8.94M | 4.46M | 2.06M | 2.11M | 1.44M |
Other Working Capital | 19.28M | -15.09M | 6.38M | -7.05M | -22.57M | 4.65M | -484K | -16.36M | 1.48M | -52K | 73.82M | 27.39M | -96.12M |
Other Non-Cash Items | 60.67M | 75.6M | 91.75M | 71.25M | 66.22M | 11.68M | -8.38M | 7.86M | 7.41M | 16.12M | -16.23M | 62.54M | 199.84M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.59M | 1.29M | 3.93M |
Change in Working Capital | -54.81M | -38.16M | -33.13M | 24.28M | -9.04M | -11.71M | -26.22M | -24.53M | -5.3M | -1.18M | 91.13M | 31.55M | -89.04M |
Operating Cash Flow | 201.43M | 147.37M | 83.16M | -546K | -132.4M | -202.61M | -245.2M | -206.28M | -136.85M | -73.93M | 338.49M | 313.45M | 292.68M |
Capital Expenditures | -54.94M | -23.91M | -16.26M | -13.46M | -8.19M | -9.4M | -8.44M | -6.15M | -4.33M | -1.74M | -992.13M | -463.25M | -363.29M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -101.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 1.87M | n/a | n/a | n/a | n/a | n/a | 61.38M | 61.38M | 61.38M | 61.38M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 198.63M | 199.18M | 182.51M |
Investing Cash Flow | -155.06M | -23.91M | -16.26M | -13.46M | -8.19M | -9.4M | 52.93M | 55.22M | 57.05M | 59.64M | -793.5M | -264.07M | -180.78M |
Debt Repayment | -8.91M | 27.74M | 27.76M | 23.78M | 23.77M | -99K | 199.82M | 199.84M | 199.87M | 199.9M | n/a | n/a | n/a |
Common Stock Repurchased | -38.01M | -16.65M | -16.67M | -16.58M | -22K | -22K | n/a | n/a | n/a | n/a | -20.73M | -20.73M | -20.73M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.88M | -28.1M | -22.9M |
Other Financial Acitivies | -12.48M | 637.2M | 638.58M | 643.16M | 647.79M | 1.59M | 471K | 224K | 111K | 210K | 163.75M | -45.88M | -168.72M |
Financial Cash Flow | -52.95M | 664.53M | 664.99M | 661.82M | 683M | 1.47M | 200.29M | 200.07M | 199.98M | 200.11M | 134.88M | -73.98M | -191.62M |
Net Cash Flow | -6.59M | 788.1M | 732.01M | 647.97M | 542.49M | -210.54M | 8.02M | 49.01M | 120.19M | 185.82M | -320.14M | -18.82M | -73.94M |
Free Cash Flow | 146.49M | 123.46M | 66.9M | -14.01M | -140.59M | -212.01M | -253.64M | -212.43M | -141.18M | -75.66M | -653.64M | -149.79M | -70.61M |
Adj. Free Cash Flow | 81.38M | 68.14M | -3.11M | -75.62M | -193.28M | -240.88M | -272.29M | -226.1M | -150.12M | -80.12M | -655.7M | -151.9M | -72.05M |
Maintenance CapEx | -16.67M | -5.07M | n/a | -2.29M | -4.12M | -6.71M | -8.44M | -39.04M | -66.68M | -92.86M | -261.35M | -244.76M | -220.41M |
Growth CapEx | -38.28M | -18.85M | -16.26M | -11.17M | -4.08M | -2.69M | n/a | -512.29M | -587.9M | -730.78M | -730.78M | -218.49M | -142.88M |
Owner Earnings | 184.77M | 142.3M | 83.16M | -2.84M | -136.52M | -209.32M | -253.64M | -147.7M | -19.65M | 92.89M | 77.14M | 68.69M | 72.27M |
Add to Watchlist
Select watchlists to add or remove CAI